ADRENOCORTICAL CARCINOMA (ACC)
Clinical trials for ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA (ACC) trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancer: radiation before surgery trial seeks to stop recurrence
Disease control Recruiting nowThis study is testing if giving targeted radiation therapy before surgery is safe and can help control a rare and aggressive adrenal gland cancer that has come back after initial treatment. It will enroll up to 32 adults whose recurrent cancer can still be surgically removed. The…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New immune drug targets liver tumors in advanced cancer trial
Disease control Recruiting nowThis study is testing whether adding a new immune-stimulating drug called PDS01ADC to a specialized liver cancer treatment can better control advanced cancers that have spread to the liver. The treatment involves surgically placing a pump that delivers chemotherapy directly to th…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC